Compared with the conditioned medium treatment group alone, we observed that the PG-treated tumor-conditioned medium (PG-TCM) significantly decreased the number of PD-1+ CD8+ T cells (Figure 4D). The gene discussed is CD8A; the disease is neoplasm.